<DOC>
	<DOC>NCT00274599</DOC>
	<brief_summary>Demonstrate that telmisartan 80mg was at least as effective and possibly superior to ramipril 5mg &amp; 10mg in lowering mean ambulatory DBP and SBP during the last 6 hrs of the 24-hr dosing interval in mild-to-moderate hypertensives at the end of 8 and 14 week treatment phases.</brief_summary>
	<brief_title>PROBE Investigation of the Safety &amp; Efficacy of Telmisartan (Micardis®) vs Ramipril (Altace®) Using ABPM in HTN</brief_title>
	<detailed_description />
	<mesh_term>Hypertension</mesh_term>
	<mesh_term>Ramipril</mesh_term>
	<mesh_term>Telmisartan</mesh_term>
	<criteria />
	<gender>All</gender>
	<minimum_age>19 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>November 2013</verification_date>
</DOC>